Codexis, Inc.
Status: Publicly traded
Direct answer
Codexis, Inc. is publicly traded on NASDAQ under the ticker CDXS.
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The...
Can you invest in Codexis, Inc.?
Yes. Codexis, Inc. trades publicly on NASDAQ as CDXS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Codexis, Inc.
Detailed equity research is provided by MarketSnap.